As of 2025-09-18, the Relative Valuation of Keros Therapeutics Inc (KROS) is 11.50 USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.62 USD, the upside of Keros Therapeutics Inc based on Relative Valuation is -26.4%.
The range of the Relative Valuation is 10.31 - 13.77 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.3x - 23.7x | 23.0x |
| Forward P/E multiples | 23.7x - 29.8x | 26.8x |
| Fair Price | 10.31 - 13.77 | 11.50 |
| Upside | -34.0% - -11.8% | -26.4% |
| Date | P/E |
| 2025-09-10 | 33.86 |
| 2025-09-09 | 33.99 |
| 2025-09-08 | 33.47 |
| 2025-09-05 | 33.73 |
| 2025-09-04 | 33.65 |
| 2025-09-03 | 34.10 |
| 2025-09-02 | 34.01 |
| 2025-08-29 | 32.91 |
| 2025-08-28 | 33.00 |
| 2025-08-27 | 33.58 |
| 2025-08-26 | 32.26 |
| 2025-08-25 | 31.94 |
| 2025-08-22 | 33.67 |
| 2025-08-21 | 32.82 |
| 2025-08-20 | 30.79 |
| 2025-08-19 | 31.35 |
| 2025-08-18 | 31.42 |
| 2025-08-15 | 31.33 |
| 2025-08-14 | 31.20 |
| 2025-08-13 | 30.21 |
| 2025-08-12 | 29.66 |
| 2025-08-11 | 28.89 |
| 2025-08-08 | 29.71 |
| 2025-08-07 | 28.91 |
| 2025-08-06 | 31.18 |
| 2025-08-05 | 31.14 |
| 2025-08-04 | 31.63 |
| 2025-08-01 | 30.98 |
| 2025-07-31 | 30.98 |
| 2025-07-30 | 31.31 |
| 2025-07-29 | 31.33 |
| 2025-07-28 | 31.40 |
| 2025-07-25 | 31.29 |
| 2025-07-24 | 31.11 |
| 2025-07-23 | 31.22 |
| 2025-07-22 | 29.71 |
| 2025-07-21 | 29.84 |
| 2025-07-18 | 29.75 |
| 2025-07-17 | 31.07 |
| 2025-07-16 | 31.35 |
| 2025-07-15 | 30.83 |
| 2025-07-14 | 31.53 |
| 2025-07-11 | 31.24 |
| 2025-07-10 | 31.31 |
| 2025-07-09 | 30.98 |
| 2025-07-08 | 30.10 |
| 2025-07-07 | 28.99 |
| 2025-07-03 | 29.10 |
| 2025-07-02 | 29.02 |
| 2025-07-01 | 28.86 |